Concepedia
Statistics
Publications
10
Citations
739
H-Index
Active since
2010
Affiliations
GlaxoSmithKline (Spain)(Current)
GlaxoSmithKline (United Kingdom)
University of Dundee
Universidad San Pablo CEU
GlaxoSmithKline (France)
Imanol Peña is an author at GlaxoSmithKline (Spain) specializing in drug discovery, pharmacology, and antileishmanial treatment.
Publications per year
2010–2023
New Compound Sets Identified from High Throughput Phenotypic Screening Against Three Kinetoplastid Parasites: An Open Resource
Imanol Peña, Marlene Manzano, Juan Cantizani et al. · Scientific Reports · 2015 · 258 citations · Full text
Pharmacy, Bioinformatics, Medicinal Chemistry +17
Preclinical candidate for the treatment of visceral leishmaniasis that acts through proteasome inhibition
Susan Wyllie, Stephen Brand, Michael G. Thomas et al. · Proceedings of the National Academy of Sciences · 2019 · 173 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +17
Automated High-Content Assay for Compounds Selectively Toxic to Trypanosoma cruzi in a Myoblastic Cell Line
Julio Alonso-Padilla, Ignacio Cotillo, Jesús L. Presa et al. · PLoS neglected tropical diseases · 2015 · 70 citations · Full text
Veterinary Medicine, Infectious Diseases, Pharmacology +16
A Replicative <i>In Vitro</i> Assay for Drug Discovery against Leishmania donovani
Diana Tegazzini, Rosario Díaz-González, Fernando Aguilar et al. · Antimicrobial Agents and Chemotherapy · 2016 · 54 citations · Full text
Veterinary Medicine, Infectious Diseases, Pharmacology +15
Identification of GSK3186899/DDD853651 as a Preclinical Development Candidate for the Treatment of Visceral Leishmaniasis
Michael G. Thomas, Manu De Rycker, Myriam Ajakane et al. · Journal of Medicinal Chemistry · 2018 · 49 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +15
1–5 of 10